BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1382012)

  • 1. Multiple myeloma. New treatment options.
    Camba L; Durie BG
    Drugs; 1992 Aug; 44(2):170-81. PubMed ID: 1382012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and therapy of multiple myeloma: current aspects].
    Betticher DC; Cerny T; Fey MF
    Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of multiple myeloma in elderly patients. New developments.
    Ossenkoppele GJ
    Drugs Aging; 1997 Aug; 11(2):152-64. PubMed ID: 9259178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Browman GP; Bergsagel D; Sicheri D; O'Reilly S; Wilson KS; Rubin S; Belch A; Shustik C; Barr R; Walker I
    J Clin Oncol; 1995 Sep; 13(9):2354-60. PubMed ID: 7666094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melphalan/prednisone versus melphalan/prednisone plus human alpha interferon therapy in patients with multiple myeloma, stages II and III. Myeloma Group of Central Sweden.
    Björkholm M
    Eur J Cancer; 1991; 27 Suppl 4():S51-2. PubMed ID: 1799480
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythropoietin in multiple myeloma].
    Pecherstorfer M; Schmoranzer F; Vesely M; Fortelny A; Baumgartner G
    Dtsch Med Wochenschr; 1990 Jul; 115(28-29):1096-9. PubMed ID: 2373040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
    McElwain TJ; Gore ME; Meldrum M; Viner C; Judson IR; Malpas JS
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():109-12. PubMed ID: 2697419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation.
    Hájek R; Adam Z; Vásová I; Král Z
    Acta Med Austriaca; 1996; 23(3):85-91. PubMed ID: 8798281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the treatment of multiple myeloma].
    Wada M; Mizoguchi H
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive therapy for myeloma.
    McElwain TJ; Meldrum M; Gore ME; Millar BC; Malpas JS
    Pathol Biol (Paris); 1990 Oct; 38(8):830. PubMed ID: 2274375
    [No Abstract]   [Full Text] [Related]  

  • 12. Current drug therapy for multiple myeloma.
    Huang YW; Hamilton A; Arnuk OJ; Chaftari P; Chemaly R
    Drugs; 1999 Apr; 57(4):485-506. PubMed ID: 10235689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma: current therapy and a glimpse of the future.
    Kyle RA
    Scand J Haematol; 1985 Jul; 35(1):38-47. PubMed ID: 3901241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study.
    Salmon SE; Crowley JJ; Grogan TM; Finley P; Pugh RP; Barlogie B
    J Clin Oncol; 1994 Nov; 12(11):2405-14. PubMed ID: 7964957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem transplants in the treatment of multiple myeloma. Pro.
    Fassas AB; Tricot G
    Clin Adv Hematol Oncol; 2004 May; 2(5):303-4. PubMed ID: 17682284
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.
    Bladé J; San Miguel JF; Fontanillas M; Alcalá A; Maldonado J; García-Conde J; Conde E; Conzález-Brito G; Moro MJ; Escudero ML; Trujillo J; Pascual A; Rozman C; Estapé J; Montserrat E
    J Clin Oncol; 1996 Jul; 14(7):2167-73. PubMed ID: 8683251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the clinical studies of alpha-interferon in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):18-29. PubMed ID: 1948125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of M2-protocol and interferon-alpha as remission induction in refractory multiple myeloma.
    Shimamoto Y; Matsuzaki M; Ono K; Sano M; Yamaguchi M
    Haematologia (Budap); 1991; 24(1):9-11. PubMed ID: 1813363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma overview.
    Soutar RL
    Scott Med J; 1998 Apr; 43(2):38-41. PubMed ID: 9717201
    [No Abstract]   [Full Text] [Related]  

  • 20. [Monoclonal gammapathy of indeterminate origin and myeloma].
    Bury J; Salmon J; Fillet G
    Rev Med Liege; 1988 Apr; 43(8):270-4. PubMed ID: 3285431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.